Lastest Insider Transactions Of AN2 Therapeutics, Inc. ( ANTX )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
ANTXAN2 Therapeutics, Inc.Easom EricChief Executive Officer2024-11-18Buy50,0001.0049,9702024-11-18 20:51:42
ANTXAN2 Therapeutics, Inc.Leonard Braden Michael 10% Owner2024-08-14Buy1,500,0001.041,560,0002024-08-14 20:24:00
ANTXAN2 Therapeutics, Inc.RA CAPITAL MANAGEMENT, L.P. 10% Owner2024-08-09Sell3,525,0941.083,807,1022024-08-13 17:03:34
ANTXAN2 Therapeutics, Inc.Zakrzewski Joseph SDirectior2024-01-18Sell100,00019.111,911,4102024-01-19 19:32:12
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior2024-01-16Sell100,00019.651,965,0002024-01-18 18:19:41
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2024-01-16Sell100,00019.651,965,0002024-01-18 18:18:45
ANTXAN2 Therapeutics, Inc.Readnour Robin ShaneDirectior2024-01-12Sell1,42521.9131,2292024-01-17 17:03:32
ANTXAN2 Therapeutics, Inc.Readnour Robin ShaneDirectior2024-01-10Sell3,66921.9380,4432024-01-12 17:08:10
ANTXAN2 Therapeutics, Inc.Krause Kevin MichaelChief Strategy Officer2024-01-09Sell7,41720.14149,3672024-01-11 19:59:41
ANTXAN2 Therapeutics, Inc.Krause Kevin MichaelChief Strategy Officer2024-01-09Option Exercise7,4174.5934,0152024-01-11 19:59:41
ANTXAN2 Therapeutics, Inc.Krause Kevin MichaelChief Strategy Officer2024-01-02Sell2,58320.1251,9672024-01-04 18:06:42
ANTXAN2 Therapeutics, Inc.Krause Kevin MichaelChief Strategy Officer2024-01-02Option Exercise2,5830.421,0852024-01-04 18:06:42
ANTXAN2 Therapeutics, Inc.Easom EricChief Executive Officer2024-01-02Sell2,77720.0955,8022024-01-04 18:05:51
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2023-11-14Sell1,81016.1529,2242023-11-16 18:59:54
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior 10% Owner2023-11-14Sell1,81016.1529,2242023-11-16 18:57:17
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior 10% Owner2023-09-29Sell104,77316.271,704,5132023-10-03 19:21:18
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2023-09-29Sell104,77316.271,704,5132023-10-03 19:13:42
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2023-09-27Sell9,35716.11150,7082023-09-29 17:41:08
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior 10% Owner2023-09-27Sell9,35716.11150,7082023-09-29 17:40:05
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior 10% Owner2023-08-23Sell40016.006,4002023-09-15 17:40:36
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2023-08-23Sell40016.006,4002023-09-15 17:17:35
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2023-08-23Sell7,14016.03114,4842023-09-08 16:59:56
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior 10% Owner2023-08-23Sell7,14016.03114,4842023-09-08 16:57:59
ANTXAN2 Therapeutics, Inc.Adjuvant Global Health Technology Fund, L.P. 10% Owner2023-08-23Sell40016.006,4002023-08-25 16:31:35
ANTXAN2 Therapeutics, Inc.Aziz KabeerDirectior 10% Owner2023-08-23Sell40016.006,4002023-08-25 16:30:49
ANTXAN2 Therapeutics, Inc.RA CAPITAL MANAGEMENT, L.P. 10% Owner2023-08-18Buy1,777,7789.0016,000,0022023-08-22 17:01:31
ANTXAN2 Therapeutics, Inc.Easom EricChief Executive Officer2023-05-15Buy10,0005.3853,7702023-05-15 20:01:16